Oxaliplatin 100mg
| Product Overview | |
| Generic Name | Oxaliplatin 100mg |
| Brand Name(s) | Eloxatin, Oxitan |
| Form | Inj Vial, powder for reconstitution |
| Strength | 100mg / 20 mL |
| Therapeutic Class | Platinum-based antineoplastic |
| ATC Code | L01XA13 |
| Manufacturing & Regulatory | |
| Manufacturer | Multiple Firms |
| Country | India |
| GMP Compliance | WHO-GMP certified facility |
| DMF/CEP | Unknown – request from mfg |
| COFEPRIS | Registered – exact Clave pending |
| Free Sale Certificate | Yes |
| Logistics & Export | |
| MOQ | 10 vials |
| Shelf Life | 12 Months |
| Storage | 2–8 °C, protected from light |
| Incoterms | Exworks, DDP, FOB |
| Lead Time | 2 - 3 wks |
| Documentation | |
| Certificate of Analysis (COA) | Manufacturer provides COA |
| SDS | Available on request |
| CTD Summary | Available upon purchase with fee |
Description
Indications & Usage: Essential in adjuvant/advanced colorectal cancer; platinum-DNA crosslinker
